BioCentury
ARTICLE | Clinical News

Xience Xpedition Everolimus Eluting Coronary Stent System regulatory update

May 27, 2013 7:00 AM UTC

Abbott received CE Mark approval for a 48 mm length of its Xience Xpedition Everolimus Eluting Coronary Stent System to treat coronary artery disease (CAD). The product is now available in Europe with...